178 related articles for article (PubMed ID: 2485442)
1. Prevention of respiratory distress syndrome: synergistic therapies.
Gross I
Mead Johnson Symp Perinat Dev Med; 1988; (33):37-41. PubMed ID: 2485442
[TBL] [Abstract][Full Text] [Related]
2. Combined effects of antenatal corticosteroids and surfactant supplementation on the outcome of very low birth weight infants.
Modanlou HD; Beharry K; Padilla G; Iriye B
J Perinatol; 1996; 16(6):422-8; quiz 429-30. PubMed ID: 8979178
[TBL] [Abstract][Full Text] [Related]
3. [Induction of fetal lung maturity with combined hormonal therapy in premature labor].
Serman F; Pazols R; Benavides C; Sandoval J; Ferres I; Lamoza P
Rev Chil Obstet Ginecol; 1994; 59(1):44-8. PubMed ID: 7809432
[TBL] [Abstract][Full Text] [Related]
4. The biochemistry of fetal lung development.
Kresch MJ; Gross I
Clin Perinatol; 1987 Sep; 14(3):481-507. PubMed ID: 3311536
[TBL] [Abstract][Full Text] [Related]
5. [Prenatal prevention of infant respiratory distress syndrome. 2nd part: clinical applications and indications].
Lenclen R; Paupe A; Philippe HJ; Olivier-Martin M; Nisand I
J Gynecol Obstet Biol Reprod (Paris); 1995; 24(3):294-309. PubMed ID: 7622778
[TBL] [Abstract][Full Text] [Related]
6. [Intrauterine stimulation for fetal respiratory system maturation; benefits and risks].
Kinalski M; Sledziewski A; Kretowski A
Wiad Lek; 2000; 53(9-10):538-45. PubMed ID: 11148922
[TBL] [Abstract][Full Text] [Related]
7. Combined hormonal therapy for the prevention of respiratory distress syndrome and its consequences.
Moya FR; Gross I
Semin Perinatol; 1993 Aug; 17(4):267-74. PubMed ID: 8140441
[TBL] [Abstract][Full Text] [Related]
8. Antenatal glucocorticoid therapy for the prevention of respiratory distress syndrome in the premature infant.
Block MF; Kling OR; Crosby WM
Obstet Gynecol; 1977 Aug; 50(2):186-90. PubMed ID: 327364
[TBL] [Abstract][Full Text] [Related]
9. Respiratory distress syndrome--new therapeutic approaches to a complex pathophysiology.
Jobe A
Adv Pediatr; 1983; 30():93-130. PubMed ID: 6369946
[TBL] [Abstract][Full Text] [Related]
10. Repeat surfactant therapy for postsurfactant slump.
Katz LA; Klein JM
J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
[TBL] [Abstract][Full Text] [Related]
11. Decreased respiratory compliance in infants less than or equal to 32 weeks' gestation, delivered more than 7 days after antenatal steroid therapy.
McEvoy C; Schilling D; Spitale P; Peters D; O'Malley J; Durand M
Pediatrics; 2008 May; 121(5):e1032-8. PubMed ID: 18450845
[TBL] [Abstract][Full Text] [Related]
12. Neonatal respiratory distress syndrome and surfactant therapy; a brief review.
Robertson B
Eur Respir J Suppl; 1989 Mar; 3():73s-76s. PubMed ID: 2662999
[TBL] [Abstract][Full Text] [Related]
13. Effects of hormones on fetal lung development.
Bizzarro MJ; Gross I
Obstet Gynecol Clin North Am; 2004 Dec; 31(4):949-61, xii. PubMed ID: 15550344
[TBL] [Abstract][Full Text] [Related]
14. [Prenatal lung maturation with corticosteroids--an overview].
Hildebrand K; Hösli I; Holzgreve W
Z Geburtshilfe Neonatol; 1996; 200(6):207-12. PubMed ID: 9081746
[TBL] [Abstract][Full Text] [Related]
15. The effects of surfactant and antenatal corticosteroid treatment on the pulmonary pathology of preterm infants with respiratory distress syndrome.
Teksam O; Kale G
Pathol Res Pract; 2009; 205(1):35-41. PubMed ID: 18951732
[TBL] [Abstract][Full Text] [Related]
16. Requirements of perinatal prevention and treatment of respiratory distress syndrome.
Di Renzo GC; Anceschi MM; Guidetti R; Cosmi EV
Eur Respir J Suppl; 1989 Mar; 3():68s-72s. PubMed ID: 2662998
[TBL] [Abstract][Full Text] [Related]
17. Surfactant sufficiency for immature infants--prenatal induction vs. postnatal treatment.
Taeusch HW; Smith BT
Eur J Respir Dis Suppl; 1987; 153():249-54. PubMed ID: 3480820
[TBL] [Abstract][Full Text] [Related]
18. Use of surfactant in the prevention and treatment of neonatal respiratory distress syndrome.
Reynolds MS; Wallander KA
Clin Pharm; 1989 Aug; 8(8):559-76. PubMed ID: 2670398
[TBL] [Abstract][Full Text] [Related]
19. Early and late surfactant treatment in preterm triplets.
Park YI; Delmore P; Bloom BT
Kans Med; 1989 Dec; 90(12):335-6. PubMed ID: 2635234
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting responses of infants with respiratory distress syndrome to exogenous surfactant therapy.
Ho NK
Singapore Med J; 1993 Feb; 34(1):74-7. PubMed ID: 8266136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
